Title:
Development of drug-discovery platform
Agreement Number:
1022292
Agreement Value:
$30,000.00
Agreement Date:
Sep 1, 2024 - Oct 31, 2025
Description:
Completion of pharmacokinetic (PK) and pharmacodynamics (PD) studies to provide essential data on how a target drug candidate is processed and delivered to the lung and assessing therapeutic effects.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Location:
Ottawa, Ontario, CA K1M 2J2
Reference Number:
172-2024-2025-Q2-1022292
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
776475691
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Mar 11, 2025
Recipient's Operating Name:
NuvoBio
Recipient's Legal Name:
NuvoBio Corporation
Federal Riding Name:
Ottawa--Vanier
Federal Riding Number:
35078
Program:
Industrial Research Assistance Program – Youth Employment Program
Program Purpose:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Coverage:
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.